Pioneering Alginate Foam Scaffolds at TERMIS

Join us at the 7th TERMIS World Congress, which will take place in Seattle, Washington, from June 25 to 28, 2024.

During this event, Mark Dreibelbis, Senior Scientist at IFF Pharma Solutions, will present groundbreaking research on macro-porous alginate foam scaffolds for 3D cell growth.

Presentation Title: Macroporous Alginate Foam Scaffolds for 3D Cell Growth
Session: Theater and Poster Sessions
Presentation Times:

Wednesday, June 26, 7:05 PM PDT (Hall 4A)
Thursday, June 27, 6:15 PM PDT (Hall 4A)

These alginate foam scaffolds are a result of IFF’s deep expertise in alginates and customization capabilities. Specifically tailored for various cell types, they provide an ideal 3D culture environment. Notably, these foam scaffolds are non-animal-based, making them suitable for tissue engineering and therapeutic screening applications.

IFF’s commitment to advancing biomedical innovation is evident through its industry leading NovaMatrix® portfolio. From controlled hydrogel technologies to advanced 3D cell culture platforms, IFF Pharma Solutions continues to explore transformative solutions for next generation biotherapeutics.

Join us at TERMIS to learn more about the impact of high-quality alginate polymers in the biomedical industry!

For additional details read our news release announcement.